Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anand A Patel
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
143 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
Luis J. Santos ReyesRecruiting - San Juan City Hospital
San Juan, Puerto Rico
Luis J. Santos ReyesRecruiting
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
Ari D. BaronRecruiting - Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
Deepa JeyakumarRecruiting - Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
Deepa JeyakumarRecruiting - Mills Health Center
San Mateo, California, United States
Ari D. BaronRecruiting - Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
Dina G. KhalafRecruiting - Miami Cancer Institute
Miami, Florida, United States
Firas El ChaerRecruiting - Memorial Hospital West
Pembroke Pines, Florida, United States
Fernando M. Vargas MaduenoRecruiting - Phoebe Putney Memorial Hospital
Albany, Georgia, United States
Vamsi KotaRecruiting - Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
Charles W. DrescherRecruiting - Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
John M. SchallenkampRecruiting - Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
Charles W. DrescherRecruiting - Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
Charles W. DrescherRecruiting - Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
Elie G. DibRecruiting - Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
Charles W. DrescherRecruiting - Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
John M. SchallenkampRecruiting - Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
John M. SchallenkampRecruiting - Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
Bryan A. FallerRecruiting - Illinois Cancercare-Canton
Canton, Illinois, United States
Bryan A. FallerRecruiting - Illinois Cancercare-Carthage
Carthage, Illinois, United States
Bryan A. FallerRecruiting - Northwestern University
Chicago, Illinois, United States
Yasmin AbazaRecruiting - Swedish Covenant Hospital
Chicago, Illinois, United States
Robert M. EisnerRecruiting - University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Anand A. PatelRecruiting - Carle at the Riverfront
Danville, Illinois, United States
Vamsi K. VasireddyRecruiting - Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
Yasmin AbazaRecruiting - Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
Bryan A. FallerRecruiting - Decatur Memorial Hospital
Decatur, Illinois, United States
Bryan A. FallerRecruiting - Illinois Cancercare-Dixon
Dixon, Illinois, United States
Bryan A. FallerRecruiting - Carle Physician Group-Effingham
Effingham, Illinois, United States
Vamsi K. VasireddyRecruiting - Crossroads Cancer Center
Effingham, Illinois, United States
Bryan A. FallerRecruiting - Illinois Cancercare-Eureka
Eureka, Illinois, United States
Bryan A. FallerRecruiting - Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
Robert M. EisnerRecruiting - Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
Bryan A. FallerRecruiting - Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, United States
Yasmin AbazaRecruiting - Northshore University Healthsystem-Glenbrook Hospital
Glenview, Illinois, United States
Robert M. EisnerRecruiting - Northwestern Medicine Glenview Outpatient Center
Glenview, Illinois, United States
Yasmin AbazaRecruiting - Northwestern Medicine Grayslake Outpatient Center
Grayslake, Illinois, United States
Yasmin AbazaRecruiting - Northshore University Healthsystem-Highland Park Hospital
Highland Park, Illinois, United States
Robert M. EisnerRecruiting - Illinois Cancercare-Kewanee Clinic
Kewanee, Illinois, United States
Bryan A. FallerRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jun 2025
- Primary completion
- 1 Mar 2027
- Completion
- 1 Mar 2027
- Last update posted
- 6 Jul 2026
- Registered enrollment
- 54
- Registry id
- NCT06577441
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.